Editas Medicine (EDIT) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$25.1 million.
- Editas Medicine's Profit After Tax rose 5958.06% to -$25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.8 million, marking a year-over-year increase of 509.9%. This contributed to the annual value of -$237.1 million for FY2024, which is 5474.13% down from last year.
- Latest data reveals that Editas Medicine reported Profit After Tax of -$25.1 million as of Q3 2025, which was up 5958.06% from -$53.2 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Profit After Tax ranged from a high of -$18.9 million in Q4 2023 and a low of -$76.1 million during Q1 2025
- In the last 5 years, Editas Medicine's Profit After Tax had a median value of -$53.2 million in 2025 and averaged -$50.4 million.
- As far as peak fluctuations go, Editas Medicine's Profit After Tax plummeted by 59983.37% in 2021, and later skyrocketed by 6892.55% in 2023.
- Editas Medicine's Profit After Tax (Quarter) stood at -$41.4 million in 2021, then crashed by 46.58% to -$60.7 million in 2022, then soared by 68.93% to -$18.9 million in 2023, then plummeted by 140.52% to -$45.4 million in 2024, then surged by 44.67% to -$25.1 million in 2025.
- Its Profit After Tax stands at -$25.1 million for Q3 2025, versus -$53.2 million for Q2 2025 and -$76.1 million for Q1 2025.